Articles tagged with Acute Inflammation
A new freeze-dried blood product called Thrombosomes has shown promise in treating traumatic brain injuries by reducing swelling and bleeding. The product, derived from platelets with trehalose preservation, has been tested on mice and found to be effective in stabilizing damaged blood vessels.
Daily aspirin use offers no quick or reliable way to prevent bowel cancer in the general population, increasing risk of serious bleeding. However, it may have potential long-term benefits for people at high genetic risk of colorectal cancer.
A new review introduces a chronological and probabilistic model to explain the recurrence of autoimmune skin diseases like vitiligo. The model proposes that full disease manifestation is the outcome of genetic susceptibility and a series of environmental or internal biological hits.
Researchers support using antibiotics for uncomplicated acute appendicitis due to low recurrence rates at 10-year follow-up. The treatment option is recommended for adult patients, reducing the need for future surgery.
A Brazilian study of nearly 900 adults under 40 found that obesity and systemic inflammation accelerate lung aging and increase the risk of chronic obstructive pulmonary disease (COPD). Smoking remains the main risk factor for lung function loss, but these two conditions can also contribute to COPD.
A new study identifies fatty acid elongase ELOVL5 as a key promoter of inflammation resolution in the lungs. The research reveals that ELOVL5 works through a dual mechanism to dampen inflammatory pathways and generate pro-resolving lipid signals.
Researchers at UT Health San Antonio School of Dentistry are studying novel targets and approaches to treat oral squamous cell carcinoma, the most common type of oral cancer. The studies aim to reduce pain management and mucositis in patients undergoing radiotherapy.
Researchers discovered that atherosclerotic plaques contain gelatinous biofilms formed by bacteria, which can trigger inflammation and rupture of the plaque leading to myocardial infarction. The study also validated an antibody targeting these bacteria, suggesting new diagnostic and therapeutic strategies for myocardial infarction.
Researchers developed a chemical probe that binds to damaged mitochondrial DNA, blocking enzymatic processes that lead to its degradation. This approach lessens mtDNA loss, preserving energy production in vulnerable tissues. The new molecule successfully reduced inflammation and maintained functional DNA despite chemical tagging.
A survey from the Orlando Health Spine Center found that Americans often opt for short-term relief methods such as rest (44%), over-the-counter pain relievers (42%), and hot/cold therapies (29%) when dealing with neck and back pain. In contrast, only 5% consider surgery as a top option for pain relief.
Researchers discover a novel metabolic pathway, glyoxalase system, that regulates excessive immune responses by targeting a previously underexplored metabolic pathway. The GLO2-SLG-D-lactylation pathway suppresses inflammatory signaling, reducing inflammation in acute and autoimmune disease settings.
Researchers have identified WSTF as a protein that could be targeted to block chronic inflammation, allowing the immune system to continue responding appropriately to short-term threats. The study's findings suggest new potential treatments targeting WSTF may combat chronic inflammatory diseases
Research at the University of Arizona Health Sciences found that certain terpenes in Cannabis sativa are effective at relieving post-surgical and fibromyalgia pain in preclinical models. Terpenes have been shown to provide significant pain relief in mouse models, with geraniol providing the most significant level of pain relief.
Researchers at Case Western Reserve University developed a method to detect inflammation using antibodies, potentially leading to blood tests for disease-specific biomarkers. The breakthrough also holds promise for drug discovery.
The study developed floating nanoballoons to improve ibuprofen's bioavailability and sustained release its anti-inflammatory effects. The formulation showed superior edema inhibition in acute inflammation studies, reducing TNF-α, hs-CRP, and IL-6 levels, while increasing anti-inflammatory IL-10 levels.
Researchers found RNA damage triggers inflammation and cell death in skin after UV exposure. The ribotoxic stress response, orchestrated by protein ZAK-alpha, plays a key role in this process.
A cohort study reports that most children and young adults with MIS-C recover quickly and have a good midterm prognosis. The study suggests that although the disease can be severe during its acute phase, it is not typically long-term.
A new implantable device, inspired by a tree branch, uses DNA sensors to continuously monitor inflammation biomarkers in the body. The device accurately measures protein biomarkers of inflammation in diabetic rats and has potential applications for managing acute and chronic conditions.
A recent study by Krishna Rao Maddipati suggests that chronic inflammation has a distinct etiology, differing from acute inflammation. The study proposes increasing anti-inflammatory compounds to treat chronic inflammation, potentially leading to new advancements in cancer therapy.
Researchers will showcase results of a randomized clinical trial demonstrating Biovanta's efficacy in reducing common cold symptoms by strengthening the respiratory barrier and controlling inflammation. The presentation will also include preclinical data on antiviral formulas targeting rhinovirus and influenza.
A nationwide Swedish study found that full vaccination significantly reduced the risk of severe cardiovascular outcomes linked to COVID-19, such as heart attack and stroke. However, temporary increases in cardiovascular risk were observed after individual doses, particularly among elderly and males.
Researchers at Rice University and Baylor College of Medicine are developing a new cell therapy platform to suppress inflammation and lung damage in ARDS patients. The platform uses engineered retinal pigment epithelial cells to locally produce anti-inflammatory agents, promising improved patient outcomes.
Researchers have explored the molecular mechanism of action of glucocorticoids, finding that they reprogram immune cell metabolism to activate natural anti-inflammatory mechanisms. The discovery could lead to development of new anti-inflammatory agents with fewer side effects.
A recent study found a compelling link between vitamin B12 deficiency and chronic inflammation, which can lead to various health problems. The research revealed an inverse relationship between vitamin B12 levels and inflammatory markers in humans and mice, suggesting that higher vitamin B12 levels may lower inflammatory markers.
Researchers found that modulating type 1 Interferon (IFN-I) signaling reduces SARS-CoV-2 replication and inflammation in rhesus macaques, offering new treatment strategies for COVID-19. The study also showed a significant reduction in viral loads with IFNmod treatment.
Pharmaceutical scientists from the National University of Singapore have developed multi-functional synthetic peptide nanonets for relieving inflammation caused by bacterial infection. These nanonets trap bacterial endotoxins and pro-inflammatory cytokines, achieving anti-inflammatory activity through selective binding.
Researchers at Garvan Institute of Medical Research found that introducing bacteria to a tumor's microenvironment triggers an immune response, activating neutrophils to destroy tumors in animal models. This breakthrough therapy targets neutrophils to improve cancer treatment outcomes.
Researchers at Karolinska Institutet discovered that electrical stimulation of the vagus nerve promotes healing in acute inflammation by shifting the balance between inflammatory and anti-inflammatory molecules. This finding opens new avenues for treating inflammatory diseases, including autoimmune and cardiovascular conditions.
A new biohybrid device can reprogram the inflammatory response at the whole-organism level, offering a foundational concept for genetically modified cells and tailored clinical applications. This innovation holds potential to prevent sepsis and other life-threatening complications associated with acute inflammation.
Researchers found that acute colitis was associated with decreased body weight, food intake, and fat content, while chronic colitis led to reduced bone mineral density and lower energy expenditure. Chronic inflammation also altered metabolism, reducing the use of nutrients as an energy source.